Correlation Between Relay Therapeutics and Structure Therapeutics
Can any of the company-specific risk be diversified away by investing in both Relay Therapeutics and Structure Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Relay Therapeutics and Structure Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Relay Therapeutics and Structure Therapeutics American, you can compare the effects of market volatilities on Relay Therapeutics and Structure Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Relay Therapeutics with a short position of Structure Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Relay Therapeutics and Structure Therapeutics.
Diversification Opportunities for Relay Therapeutics and Structure Therapeutics
0.52 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Relay and Structure is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Relay Therapeutics and Structure Therapeutics America in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Structure Therapeutics and Relay Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Relay Therapeutics are associated (or correlated) with Structure Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Structure Therapeutics has no effect on the direction of Relay Therapeutics i.e., Relay Therapeutics and Structure Therapeutics go up and down completely randomly.
Pair Corralation between Relay Therapeutics and Structure Therapeutics
Given the investment horizon of 90 days Relay Therapeutics is expected to generate 0.71 times more return on investment than Structure Therapeutics. However, Relay Therapeutics is 1.42 times less risky than Structure Therapeutics. It trades about -0.27 of its potential returns per unit of risk. Structure Therapeutics American is currently generating about -0.21 per unit of risk. If you would invest 564.00 in Relay Therapeutics on September 1, 2024 and sell it today you would lose (94.00) from holding Relay Therapeutics or give up 16.67% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Relay Therapeutics vs. Structure Therapeutics America
Performance |
| Timeline |
| Relay Therapeutics |
| Structure Therapeutics |
Relay Therapeutics and Structure Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Relay Therapeutics and Structure Therapeutics
The main advantage of trading using opposite Relay Therapeutics and Structure Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Relay Therapeutics position performs unexpectedly, Structure Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will offset losses from the drop in Structure Therapeutics' long position.| Relay Therapeutics vs. Stoke Therapeutics | Relay Therapeutics vs. Pliant Therapeutics | Relay Therapeutics vs. Black Diamond Therapeutics | Relay Therapeutics vs. Arvinas |
| Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. X4 Pharmaceuticals | Structure Therapeutics vs. Inozyme Pharma | Structure Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Stocks Directory Find actively traded stocks across global markets |